NAVB Annual ROE
179.91%
+1058.09%+120.49%
31 December 2022
Summary:
As of January 23, 2025, NAVB annual return on equity is 179.91%, with the most recent change of +1058.09% (+120.49%) on December 31, 2022. During the last 3 years, it has risen by +1611.54% (+112.57%). NAVB annual ROE is now -83.11% below its all-time high of 1064.93%, reached on December 31, 2013.NAVB ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NAVB Quarterly ROE
20.90%
-55.35%-72.59%
30 September 2023
Summary:
As of January 23, 2025, NAVB quarterly return on equity is 20.90%, with the most recent change of -55.35% (-72.59%) on September 30, 2023. Over the past year, it has dropped by -55.35% (-72.59%). NAVB quarterly ROE is now -99.99% below its all-time high of 360.26 thousand%, reached on December 31, 2017.NAVB Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NAVB ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +120.5% | -72.6% |
| 3 y3 years | +112.6% | -72.6% |
| 5 y5 years | -72.7% | -72.6% |
NAVB ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +120.5% | -95.9% | +101.7% |
| 5 y | 5-year | at high | +109.8% | -98.7% | +100.4% |
| alltime | all time | -83.1% | +109.8% | -100.0% | +100.0% |
Navidea Biopharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2023 | - | 20.90%(-72.6%) |
| June 2023 | - | 76.25%(-61.3%) |
| Mar 2023 | - | 196.86%(-34.1%) |
| Dec 2022 | 179.91%(-120.5%) | 298.61%(-41.6%) |
| Sept 2022 | - | 511.50%(-141.0%) |
| June 2022 | - | -1246.35%(+199.0%) |
| Mar 2022 | - | -416.88%(+29.7%) |
| Dec 2021 | -878.18%(-52.3%) | -321.38%(+9.2%) |
| Sept 2021 | - | -294.21%(-33.9%) |
| June 2021 | - | -444.91%(-57.6%) |
| Mar 2021 | - | -1050.40%(-165.9%) |
| Dec 2020 | -1839.18%(+28.5%) | 1593.82%(+109.8%) |
| Sept 2020 | - | 759.63%(+14.7%) |
| June 2020 | - | 662.34%(-111.4%) |
| Mar 2020 | - | -5821.25%(+374.6%) |
| Dec 2019 | -1431.63%(+542.3%) | -1226.59%(+59.1%) |
| Sept 2019 | - | -770.79%(+30.5%) |
| June 2019 | - | -590.42%(+22.5%) |
| Mar 2019 | - | -481.78%(+44.7%) |
| Dec 2018 | -222.89%(-133.8%) | -332.86%(+48.0%) |
| Sept 2018 | - | -224.96%(+64.0%) |
| June 2018 | - | -137.18%(+14.8%) |
| Mar 2018 | - | -119.45%(-100.0%) |
| Dec 2017 | 658.60%(+3036.2%) | 360.26 K%(<-9900.0%) |
| Sept 2017 | - | -2083.94%(+540.6%) |
| June 2017 | - | -325.30%(+89.9%) |
| Mar 2017 | - | -171.28%(-861.2%) |
| Dec 2016 | 21.00%(-58.6%) | 22.50%(+4.6%) |
| Sept 2016 | - | 21.51%(-41.3%) |
| June 2016 | - | 36.65%(-19.9%) |
| Mar 2016 | - | 45.78%(-22.1%) |
| Dec 2015 | 50.76%(-57.7%) | 58.79%(-24.9%) |
| Sept 2015 | - | 78.31%(-9.6%) |
| June 2015 | - | 86.61%(-16.4%) |
| Mar 2015 | - | 103.61%(-27.9%) |
| Dec 2014 | 119.87%(-88.7%) | 143.61%(-37.9%) |
| Sept 2014 | - | 231.23%(-58.7%) |
| June 2014 | - | 559.93%(-65.6%) |
| Mar 2014 | - | 1625.82%(-102.9%) |
| Dec 2013 | 1064.93%(-460.2%) | -56.74 K%(+1675.1%) |
| Sept 2013 | - | -3196.68%(+26.6%) |
| June 2013 | - | -2525.80%(+298.3%) |
| Mar 2013 | - | -634.14%(+105.0%) |
| Dec 2012 | -295.62%(-765.2%) | -309.40%(+61.4%) |
| Sept 2012 | - | -191.75%(+5040.8%) |
| June 2012 | - | -3.73%(-119.3%) |
| Mar 2012 | - | 19.31%(-53.0%) |
| Dec 2011 | 44.44%(-103.7%) | 41.09%(-64.5%) |
| Sept 2011 | - | 115.63%(-147.1%) |
| June 2011 | - | -245.30%(-94.9%) |
| Mar 2011 | - | -4810.07%(-174.3%) |
| Dec 2010 | -1209.31%(-401.4%) | 6471.51%(+473.6%) |
| Sept 2010 | - | 1128.28%(+13.9%) |
| June 2010 | - | 990.88%(+249.6%) |
| Mar 2010 | - | 283.45%(+15.5%) |
| Dec 2009 | 401.28%(+135.0%) | 245.50%(-12.7%) |
| Sept 2009 | - | 281.12%(+97.7%) |
| June 2009 | - | 142.20%(+112.7%) |
| Mar 2009 | - | 66.84%(-78.3%) |
| Dec 2008 | 170.74% | 308.53%(+0.6%) |
| Sept 2008 | - | 306.54%(+25.3%) |
| June 2008 | - | 244.74%(+20.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2008 | - | 202.85%(-6.7%) |
| Dec 2007 | 129.02%(-150.6%) | 217.48%(-30.7%) |
| Sept 2007 | - | 313.89%(-57.0%) |
| June 2007 | - | 729.32%(-239.7%) |
| Mar 2007 | - | -522.13%(+122.0%) |
| Dec 2006 | -254.99%(+163.3%) | -235.24%(+55.6%) |
| Sept 2006 | - | -151.19%(+48.6%) |
| June 2006 | - | -101.74%(+13.2%) |
| Mar 2006 | - | -89.85%(+9.3%) |
| Dec 2005 | -96.83%(+56.2%) | -82.20%(-8.6%) |
| Sept 2005 | - | -89.91%(+28.1%) |
| June 2005 | - | -70.17%(+25.1%) |
| Mar 2005 | - | -56.07%(+3.3%) |
| Dec 2004 | -62.00%(+58.9%) | -54.30%(+76.1%) |
| Sept 2004 | - | -30.84%(-27.0%) |
| June 2004 | - | -42.27%(+3.7%) |
| Mar 2004 | - | -40.75%(-8.3%) |
| Dec 2003 | -39.03%(-28.5%) | -44.44%(+23.0%) |
| Sept 2003 | - | -36.12%(-16.1%) |
| June 2003 | - | -43.04%(-23.1%) |
| Mar 2003 | - | -55.98%(-0.7%) |
| Dec 2002 | -54.56%(<-9900.0%) | -56.37%(-15.0%) |
| Sept 2002 | - | -66.31%(+69.5%) |
| June 2002 | - | -39.12%(+96.4%) |
| Mar 2002 | - | -19.92%(-5342.1%) |
| Dec 2001 | 0.30%(-99.8%) | 0.38%(-99.2%) |
| Sept 2001 | - | 45.74%(-18.6%) |
| June 2001 | - | 56.22%(-35.9%) |
| Mar 2001 | - | 87.71%(+24.5%) |
| Dec 2000 | 130.19%(-173.1%) | 70.46%(-914.6%) |
| Sept 2000 | - | -8.65%(-84.3%) |
| June 2000 | - | -55.01%(-72.4%) |
| Mar 2000 | - | -199.13%(+11.5%) |
| Dec 1999 | -178.12%(+18.8%) | - |
| June 1999 | - | -178.59%(+15.6%) |
| Mar 1999 | - | -154.55%(+8.3%) |
| Dec 1998 | -149.99%(+183.4%) | -142.76%(+57.9%) |
| Sept 1998 | - | -90.43%(+23.0%) |
| June 1998 | - | -73.50%(+10.2%) |
| Mar 1998 | - | -66.72%(+27.5%) |
| Dec 1997 | -52.92%(-5.1%) | -52.33%(-4.9%) |
| Sept 1997 | - | -55.04%(+10.0%) |
| June 1997 | - | -50.04%(+2.1%) |
| Mar 1997 | - | -49.02%(-9.2%) |
| Dec 1996 | -55.78%(+3.3%) | -54.01%(+11.2%) |
| Sept 1996 | - | -48.59%(-10.3%) |
| June 1996 | - | -54.16%(-21.7%) |
| Mar 1996 | - | -69.19%(+9.7%) |
| Dec 1995 | -54.00%(-23.0%) | -63.08%(-9.8%) |
| Sept 1995 | - | -69.97%(-24.2%) |
| June 1995 | - | -92.35%(-8.3%) |
| Mar 1995 | - | -100.76%(+2.8%) |
| Dec 1994 | -70.13%(+1.7%) | -97.99%(-21.8%) |
| Sept 1994 | - | -125.30%(+14.8%) |
| June 1994 | - | -109.15%(+9.6%) |
| Mar 1994 | - | -99.57%(+25.0%) |
| Dec 1993 | -68.97%(+228.9%) | -79.68%(+12.3%) |
| Sept 1993 | - | -70.95%(+33.0%) |
| June 1993 | - | -53.33%(+68.3%) |
| Mar 1993 | - | -31.69%(+62.2%) |
| Dec 1992 | -20.97% | -19.54%(+8.6%) |
| Sept 1992 | - | -18.00% |
FAQ
- What is Navidea Biopharmaceuticals annual return on equity?
- What is the all time high annual ROE for Navidea Biopharmaceuticals?
- What is Navidea Biopharmaceuticals annual ROE year-on-year change?
- What is Navidea Biopharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Navidea Biopharmaceuticals?
- What is Navidea Biopharmaceuticals quarterly ROE year-on-year change?
What is Navidea Biopharmaceuticals annual return on equity?
The current annual ROE of NAVB is 179.91%
What is the all time high annual ROE for Navidea Biopharmaceuticals?
Navidea Biopharmaceuticals all-time high annual return on equity is 1064.93%
What is Navidea Biopharmaceuticals annual ROE year-on-year change?
Over the past year, NAVB annual return on equity has changed by +1058.09% (+120.49%)
What is Navidea Biopharmaceuticals quarterly return on equity?
The current quarterly ROE of NAVB is 20.90%
What is the all time high quarterly ROE for Navidea Biopharmaceuticals?
Navidea Biopharmaceuticals all-time high quarterly return on equity is 360.26 K%
What is Navidea Biopharmaceuticals quarterly ROE year-on-year change?
Over the past year, NAVB quarterly return on equity has changed by -55.35% (-72.59%)